市場調查報告書
商品編碼
1461635
全球適體市場規模、佔有率、成長分析,依類型(核酸和胜肽)、依應用(診斷、治療)- 2024-2031 年產業預測Global Aptamers Market Size, Share, Growth Analysis, By Type(Nucleic Acid and Peptide), By Application(Diagnostics, Therapeutics) - Industry Forecast 2024-2031 |
2022年全球適體市場規模為12.0億美元,預計將從2023年的1.43億美元成長到2031年的58.3億美元,預測期間(2024-2031年)複合年成長率為19.2%。
適配體因其在生產、純化和標靶藥物遞送方面的獨特優勢而引起了研究人員的極大興趣,與抗體相比具有分子尺寸小、免疫原性低、成本效益高、副作用少等優點。這刺激了適體開發的創新,有可能擴大市場。儘管存在各種遺傳變異,但目前的感染療法缺乏有效性,因此需要先進的解決方案。基於 SELEX 技術的診斷試劑盒有望生產高親和力中和劑,這可能會推動市場擴張。基於適配體的診斷試劑盒,與第二代基於DNA 適配體的適配體一樣,提供經濟高效的化學合成解決方案,例如EPIC 研究中使用的Soma Logic 的SomaScan Assay,可實現更深入的疾病了解並促進市場成長,以滿足日益成長的需求。基於適配體的診斷解決方案體積小、特異性高、選擇性高且功效高,是細胞層面疾病診斷的首選,可滿足到 2040 年癌症診斷的預期成長。
Global Aptamers Market size was valued at USD 1.20 billion in 2022 and is poised to grow from 1.43 USD billion in 2023 to USD 5.83 billion by 2031, at a CAGR of 19.2% during the forecast period (2024-2031).
Aptamers have attracted significant interest from researchers due to their distinct advantages in production, purification, and targeted drug delivery, offering benefits such as small molecular size, low immunogenicity, cost-effectiveness, and reduced side effects compared to antibodies. This has spurred innovation in aptamer development, potentially expanding the market. Despite various genetic variations, current therapies for infections lack effectiveness, prompting the need for advanced solutions. SELEX technology-based diagnostic kits offer promise in producing high-affinity neutralizers, likely driving market expansion. Aptamer-based diagnostic kits, like the second-generation DNA aptamer-based Aptamer, offer cost-effective and chemically synthesized solutions, exemplified by Soma Logic's SomaScan Assay, utilized in the EPIC research, enabling deeper disease understanding and facilitating market growth to meet rising cancer diagnostic demands predicted by Cancer Research UK. With their small size, high specificity, selectivity, and efficacy, aptamer-based diagnostic solutions are preferred in cellular-level disease diagnosis, catering to the anticipated increase in cancer diagnoses by 2040.
Top-down and bottom-up approaches were used to estimate and validate the size of the global aptamers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Aptamers Market Segmental Analysis
Global Aptamers Market is segmented on the basis of type, application and region. By type, the market is segmented into nucleic acid and peptide. By application, market is segmented into diagnostics, therapeutics, research & development, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Aptamers Market
Aptamers are integral to personalized medicine due to their ability to selectively bind to various target molecules like proteins, peptides, and small molecules. With the rising focus on tailored therapies and precision medicine, there's a heightened need for aptamers owing to their distinct benefits such as exceptional specificity, minimal immunogenicity, and customizable attributes. By facilitating precise molecular recognition, aptamers pave the way for the formulation of individualized treatment approaches, thereby playing a pivotal role in advancing personalized medicine strategies.
Restraints in the Global Aptamers Market
The advancement of the aptamers market faces obstacles due to intellectual property (IP) challenges, wherein patent rights and licensing agreements concerning aptamers and associated technologies may constrain their commercialization potential, particularly for specific applications or targets. The intricate IP landscape surrounding aptamer-based technologies introduces legal uncertainties and potential obstacles for market participants, impeding their growth prospects.
Market Trends of the Global Aptamers Market
The primary technique for aptamer selection, known as SELEX (Systematic Evolution of Ligands by Exponential Enrichment), is increasingly emphasizing optimization and automation to bolster efficiency, cut down expenses, and enhance the quality of aptamers. Innovations in high-throughput screening, microfluidics, and robotics are being harnessed to streamline the aptamer development workflow, thus democratizing and scaling up the process for wider accessibility.